Drugresistant tuberculosis (DRTB) is a growing global health threat, with high mortality rates, exorbitant treatment costs, and increased transmission risks. In 2021, there were approximately 450,000 DRTB cases reported worldwide, resulting in 191,000 deaths. South Africa has one of the highest DRTB burdens, but only half of the patients initiate treatment.
